M6P-modified solid lipid nanoparticles loaded with matrine for the treatment of fibrotic liver

References

• Ban C, Lim S, Chang PS, Choi YJ. (2014). Enhancing the stability of lipid nanoparticle systems by sonication during the cooling step and controlling the liquid oil content. J Agric Food Chem 62:1–16.
   PubMed Web of Science ®Google Scholar
• Bartneck M, Warzecha KT, Tacke F. (2014). Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg Nutr 36:364–76.
   Google Scholar
• Bataller R, Brenner DA. (2005). Liver fibrosis. J Clin Invest 115:209–18.
   PubMed Web of Science ®Google Scholar
• Batool S, Zahid F, Ud-Din F, et al. (2021). Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses. Drug Dev Ind Pharm 47:440–53.
   PubMed Web of Science ®Google Scholar
• Beljaars L, Molema G, Weert B, et al. (1999). Albumin modified with mannose 6-phosphate: a potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Hepatology 29:1486–93.
   PubMed Web of Science ®Google Scholar
• Byass P. (2014). The global burden of liver disease: a challenge for methods and for public health. BMC Med 12:159.
   PubMed Web of Science ®Google Scholar
• Dai ZJ, Gao J, Ji ZZ, et al. (2009). Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol 123:91–6.
   PubMed Web of Science ®Google Scholar
• Din FU, Mustapha O, Kim DW, et al. (2015). Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Eur J Pharm Biopharm 94:64–72.
   PubMed Web of Science ®Google Scholar
• Din F. u, Zeb A, Shah KU, Zia Ur R. (2019). Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product. J Drug Delivery Sci Technol 51:583–90.
   Web of Science ®Google Scholar
• Feng Y, Ying HY, Qu Y, et al. (2016). Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells. Protein Cell 7:662–72.
   PubMed Web of Science ®Google Scholar
• Gonzalo T, Talman EG, van de Ven A, et al. (2006). Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology. J Control Release 111:193–203.
   PubMed Web of Science ®Google Scholar
• Greupink R, Bakker HI, Bouma W, et al. (2006). The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo. J Pharmacol Exp Ther 317:514–21.
   PubMed Web of Science ®Google Scholar
• Greupink R, Bakker HI, Reker-Smit C, et al. (2005). Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell. J Hepatol 43:884–92.
   PubMed Web of Science ®Google Scholar
• Hagens WI, Olinga P, Meijer DK, et al. (2006). Gliotoxin non-selectively induces apoptosis in fibrotic and normal livers. Liver Int 26:232–9.
   PubMed Web of Science ®Google Scholar
• Jiang JH, Pi J, Jin H, et al. (2018). Chinese herb medicine matrine induce apoptosis in human esophageal squamous cancer KYSE-150 cells through increasing reactive oxygen species and inhibiting mitochondrial function. Pathol Res Pract 214:691–9.
   PubMed Web of Science ®Google Scholar
• Jin W, Xu P, Zhan Y, et al. (2007). Degradable cisplatin-releasing core-shell nanogels from zwitterionic poly(beta -aminoester)-graft-PEG for cancer chemotherapy. Drug Deliv 14:279–86.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner DA. (2008). Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233:109–22.
   PubMed Web of Science ®Google Scholar
• Kong WH, Park K, Lee MY, et al. (2013). Cationic solid lipid nanoparticles derived from apolipoprotein-free LDLs for target specific systemic treatment of liver fibrosis. Biomaterials 34:542–51.
   PubMed Web of Science ®Google Scholar
• Kumar S, Randhawa JK. (2013a). Preparation and characterization of Paliperidone loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces 102:562–8.
   PubMed Web of Science ®Google Scholar
• Kumar S, Randhawa JK. (2013b). High melting lipid based approach for drug delivery: solid lipid nanoparticles. Mater Sci Eng C Mater Biol Appl 334:1842–52.
   Google Scholar
• Li W, Zhou C, Fu Y, et al. (2020). Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats. Acta Pharm Sin B 10:693–710.
   PubMed Web of Science ®Google Scholar
• Luk JM, Zhang QS, Lee NP, et al. (2007). Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model. Liver Int 27:548–57.
   PubMed Web of Science ®Google Scholar
• Ma L, Wen S, Zhan Y, et al. (2008). Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med 74:245–51.
   PubMed Web of Science ®Google Scholar
• Mahdinloo S, Hemmati S, Valizadeh H, et al. (2022). Synthesis and preparation of vitamin A coupled butein-loaded solid lipid nanoparticles for liver fibrosis therapy in rats. Int J Pharm 625:122063.
   PubMedGoogle Scholar
• Mederacke I, Hsu CC, Troeger JS, et al. (2013). Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 4:2823.
   PubMed Web of Science ®Google Scholar
• Mirchandani Y, Patravale VB, S B. (2021). Solid lipid nanoparticles for hydrophilic drugs. J Control Release 335:457–64.
   PubMed Web of Science ®Google Scholar
• Rahman HS, Rasedee A, How CW, et al. (2013). Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine 8:2769–81.
   PubMed Web of Science ®Google Scholar
• Rana I, Khan N, Ansari MM, et al. (2020). Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model. Colloids Surf B Biointerfaces 194:111209.
   PubMed Web of Science ®Google Scholar
• Sakaida I, Terai S, Yamamoto N, et al. (2004). Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 40:1304–11.
   PubMed Web of Science ®Google Scholar
• Song K, Hao Y, Tan X, et al. (2023). Microneedle-mediated delivery of Ziconotide-loaded liposomes fused with exosomes for analgesia. J Control Release 356:448–62.
   PubMed Web of Science ®Google Scholar
• Xing R, Mustapha O, Ali T, et al. (2021). Development, characterization, and evaluation of SLN-loaded thermoresponsive hydrogel system of topotecan as biological macromolecule for colorectal delivery. Biomed Res Int 2021:9968602.
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen L, Gu W, et al. (2009). The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 30:226–32.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhao C, Yang H, et al. (2011). Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers. Drug Deliv 18:485–92.
   PubMed Web of Science ®Google Scholar
• Yang B, Jiang J, Jiang L, et al. (2020). Chitosan mediated solid lipid nanoparticles for enhanced liver delivery of zedoary turmeric oil in vivo. Int J Biol Macromol 149:108–15.
   PubMed Web of Science ®Google Scholar
• Zhang JP, Min Z, Jin C. (2001). Matrine inhibits production and actions of fibrogenic cytokines released by mouse peritoneal macrophages. Acta Pharmacol Sin 228:765–8.
   Google Scholar
• Zhang Y, Zhang N, Song H, et al. (2019). Design, characterization and comparison of transdermal delivery of colchicine via borneol-chemically-modified and borneol-physically-modified ethosome. Drug Deliv 26:70–7.
   PubMed Web of Science ®Google Scholar